A Single Dose, 2-Period, 2-Treatment, 2-Way Crossover Bioequivalency Study of Balsalazide Disodium 750 mg Capsules Under Fasting Conditions

Clinical trial NCT00618202 · COMPLETED

Trial details

NCT number: NCT00618202
Sponsor: Roxane Laboratories
Status: COMPLETED
Phase: Not Applicable
Study type: INTERVENTIONAL

Ulcerative Colitis

Start date: 2005-05-01
Primary completion: 2005-06-01
Enrollment: 52

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.